The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Increased β-Cell Secretory Capacity as Mechanism for Islet Adaptation to Nicotinic Acid-Induced Insulin Resistance
Abstract
To determine whether prolonged nicotinic acid (NA) administration produces insulin resistance and, if so, how the normal pancreatic islet adapts to prolonged insulin resistance, we administered incremental doses of NA to 11 normal men for 2 wk, ending at 2 g/day. Insulin sensitivity was measured with Bergman's minimal model. Islet function was evaluated by measurement of acute insulin (AIR) and glucagon (AGR) responses to arginine at three glucose levels. Insulin resistance was demonstrated and quantified by a marked drop in the insulin sensitivity index (S1) from 6.72 ± 0.77 to 2.47 ± 0.36 × 10−5 min−1/pM (P < .0001) and resulted in a doubling of basal immunoreactive insulin levels (from 75 ± 7 to 157 ± 21 pM, P < .001) with no change in fasting glucose (5.5 ± 0.1 vs. 5.7 ± 0.1 mM). Proinsulin levels also increased (from 9 ± 1 to 15 ± 2 pM, P < .005), but the ratio of proinsulin to immunoreactive insulin did not change (12.7 ± 1.9 vs. 10.3 ± 1.9%). β-Cell changes were characterized by increases in the AIR to glucose (from 548 ± 157 to 829 ± 157 pM, P < .005) and in the AIR to arginine at the fasting glucose level (from 431 ± 54 to 788 ± 164 pM, P < .05). At the maximal hyperglycemia level the AIR to arginine represents β-cell secretory capacity, and this increased with administration of NA (from 2062 ± 267 to 2630 ± 363 pM, P < .05). From the AIRs to arginine an estimate of the glucose level giving half-maximal AIR to arginine can be calculated. This measure did not increase (10.0 ± 0.5 vs. 9.6 ± 0.9 mM). The AGRs to argininewere reduced at all glucose levels during NA administration. Thus, the pancreatic islet adapts to the prolonged insulin resistance induced by NA. This adaptation comprises a combination of increased insulin secretion and reduced glucagon secretion. The changes in insulin secretion can be entirely explained by an increase in the secretory capacity of the β-cell.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while insulin secretion increased in response to nicotinic acid-induced insulin resistance, this compensation was incomplete.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [28]
In the citing paper
“the variation in insulin release that occurs in response to differences in insulin sensitivity is the result of changes in the secretory capacity of the beta cell and not its sensitivity to glucose [28, 54] (Fig. 2B).”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [28]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 101–179 of 179
Hirsch, D., Odorico, J. S., Radke, N. A., Hanson, M. S., Danobeitia, J. S., Hullett, D. A., Alejandro, R., Ricordi, C., & Fernandez, L. A. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01290.x · Cited by 27
Ginsberg, H. N., & Reyes‐Soffer, G. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000017 · Cited by 27
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2015) · Cited by 27
Sung, Y., Hsiao, C., Chang, I.-J., Lin, Y., & Yueh, C.-Y. (2016) · Journal of Diabetes Research · doi:10.1155/2016/3961756 · Cited by 26
Gardner, S. F., Marx, M. A., White, L. M., Granberry, M. C., Skelton, D. R., & Fonseca, V. A. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703100602 · Cited by 26
Medical myths involving diabetes
Adler, E., & Paauw, D. S. (2003) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(03)00032-0 · Cited by 27
Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation
Christiansen, E., Tibell, A., Vølund, A., Rasmussen, K. K., Groth, C. G., Holst, J. J., Pedersen, O. B., Christensen, N. J., & Madsbad, S. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.11.8923846 · Cited by 25
Age-related differences in the pancreatic β-cell response to hyperglycemia after eccentric exercise
Krishnan, R. K., Hernandez, J. M., Williamson, D. L., O’Gorman, D. J., Evans, W. J., & Kirwan, J. P. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.3.e463 · Cited by 25
Management of the metabolic syndrome—nicotinic acid
Meyers, C. D., & Kashyap, M. L. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.014 · Cited by 25
Insulin and atherosclerosis: villain, accomplice, or innocent bystander?
Savage, P. J., & Saad, M. F. (1993) · Heart · doi:10.1136/hrt.69.6.473 · Cited by 25
Hypertriglyceridemia and Coronary Heart Disease
Oberman, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.6.2098 · Cited by 22
Prigeon, R. L., Kahn, S. E., & Porte, D. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.2.e279 · Cited by 22
Self-citationIslet Phospholipase A2 Activation Is Potentiated in Insulin Resistant Mice
Simonsson, E., Karlsson, S., & Åhrén, B. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2820 · Cited by 21
Inoguchi, T., Umeda, F., KAKIMOTO, M., Sako, Y., Ishii, H., NODA, K., Kunisaki, M., Imamura, M., YU, H.-Y., Etoh, T., et al. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.763 · Cited by 21
Vlasáková, Z., Pelikánová, T., Karasová, L., & Skibová, J. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.030 · Cited by 21
Reduction of free fatty acids may ameliorate risk factors associated with abdominal obesity
McCarty, M. F. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90180-9 · Cited by 20
Prigeon, R. L., Jacobson, R. K., Porte, D., & Kahn, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784086 · Cited by 21
Self-citationBroussard, J. L., Kolka, C. M., Castro, A. V., Bediako, I. A., Paszkiewicz, R. L., Szczepaniak, E. W., Szczepaniak, L. S., Knutson, K. L., Kim, S. P., & Bergman, R. N. (2015) · Diabetologia · doi:10.1007/s00125-015-3721-6 · Cited by 20
Self-citationKoh, Y., Bidstrup, H., & Nichols, D. (2014) · International Journal of Women s Health · doi:10.2147/ijwh.s69908 · Cited by 20
Manetta, J., Brun, J., Callis, A., Mercier, J., & Préfaut, C. (2001) · Metabolism: Clinical and Experimental · doi:10.1053/meta.2001.20205 · Cited by 26
Drug-induced hyperglycemia and diabetes
Heurtebize, M.-A., & Faillie, J. (2023) · Therapies · doi:10.1016/j.therap.2023.09.010 · Cited by 19
Ellero‐Simatos, S., Szymańska, E., Rullmann, T., Dokter, W. H. A., Ramaker, R., Berger, R., van Iersel, T. M., Smilde, A. K., Hankemeier, T., & Alkema, W. B. L. (2012) · Genome Medicine · doi:10.1186/gm395 · Cited by 19
Treatment of Non-Insulin-Dependent Diabetes Mellitus and its Complications
Ilarde, A., & Tuck, M. L. (1994) · Drugs & Aging · doi:10.2165/00002512-199404060-00004 · Cited by 20
Beta-cell function is associated with metabolic syndrome in Mexican subjects
Pérez-Fuentes, R. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s12375 · Cited by 18
Nicotinamide and insulin secretion in normal subjects
Bingley, P. J., Caldas, G., Bonfanti, R., & Gale, E. A. M. (1993) · Diabetologia · doi:10.1007/bf00404080 · Cited by 18
Bertuzzi, F., Saccomanno, K., SOCCI, C., Davalli, A. M., Taglietti, M. V., Berra, C., Dalcin, E., Monti, L., Pozza, G., & Pontiroli, A. E. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1580205 · Cited by 17
Fraterrigo, G., Fabbrini, E., Mittendorfer, B., O’Rahilly, S., Scherer, P. E., Patterson, B. W., & Klein, S. (2012) · Cardiorenal Medicine · doi:10.1159/000340037 · Cited by 16
Wahlberg, G., Walldius, G., & Efendić, S. (1992) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519209090131 · Cited by 16
Coronary Heart Disease Risk, Dyslipidemia, and Management in HIV-Infected Persons
Fichtenbaum, C. J. (2004) · HIV Clinical Trials · doi:10.1310/p07m-hnt8-l08g-5tku · Cited by 15
McKenney, J. M. (1993) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1993.tb02741.x · Cited by 15
Proinsulin immunoreactivity in identical twins discordant for noninsulin-dependent diabetes mellitus
Røder, M. E., Vaag, A. A., HARTLING, S. G., Dinesen, B., Lanng, S., Beck‐Nielsen, H., & Binder, C. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.8.7629230 · Cited by 15
Beta-cell function is associated with metabolic syndrome in Mexican subjects
Pérez-Fuentes (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s12375 · Cited by 14
Araújo‐Vilar, D., Estévez, D. A. G., & Cabezas-Cerrato, J. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90263-3 · Cited by 15
In vivo β-cell function at the transition to early non-insulin-dependent diabetes mellitus
Swinburn, B. A., Gianchandani, R. Y., Saad, M. F., & Lillioja, S. (1995) · Metabolism · doi:10.1016/0026-0495(95)90189-2 · Cited by 14
Insights on the Role of Putative Muscle-Derived Factors on Pancreatic Beta Cell Function
Mizgier, M. L., Fernández‐Verdejo, R., Cherfan, J., Pinget, M., Bouzakri, K., & Galgani, J. E. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01024 · Cited by 14
Khan, B. V. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3460 · Cited by 13
Saraiya, A. R., Al-Shoha, A., & Brodell, R. T. (2013) · Endocrine Practice · doi:10.4158/ep12192.ra · Cited by 12
Excessive nicotinic acid increases methyl consumption and hydrogen peroxide generation in rats
Li, D., Luo, N., Ma, Q., Li, S., Shi, Q., Cao, Y. Q., & Zhou, S. (2012) · Pharmaceutical Biology · doi:10.3109/13880209.2012.697175 · Cited by 12
Management of Hyperlipidemia in Diabetes Mellitus
Dunn, F. L. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30223-8 · Cited by 11
Chebane, L., Tavassoli, N., Bagheri, H., & Jean-LouisMontastruc (2010) · Therapies · doi:10.2515/therapie/2010051 · Cited by 10
Røder, M. E., & Kahn, S. E. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s22 · Cited by 10
Self-citationGupta, N., Hoffman, R. P., & Veng‐Pedersen, P. (2005) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.461 · Cited by 10
Cardiovascular complications of type 2 diabetes in youth
Kehler, D. S., Stammers, A. N., Susser, S. E., Hamm, N. C., Kimber, D. E., Hlynsky, M. W., & Duhamel, T. A. (2014) · Biochemistry and Cell Biology · doi:10.1139/bcb-2014-0118 · Cited by 9
Hyperproinsulinemia in obesity and in type 2 diabetes and its relation to cardiovascular disease
Røder, M. E. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1331735 · Cited by 8
Garber, A. J. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00100.x · Cited by 8
R�der, M. E., Eriksson, J. G., HARTLING, S. G., Groop, P., & Binder, C. (1993) · Acta Diabetologica · doi:10.1007/bf00572856 · Cited by 8
Hajifaraji, M., & Leeds, A. (2008) · PubMed · Cited by 7
Regulation of Insulin Secretion in Vivo
Vidal, J., & Kahn, S. E. (2001) · Endocrine updates · doi:10.1007/978-1-4615-1597-5_7 · Cited by 7
Self-citationInsulin and Glucagon Secretion in vivo and its Neural Control
Taborsky, G. J. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070206 · Cited by 7
Self-citationNicotinic Signaling Stimulates Glucagon Secretion in Mouse and Human Pancreatic α-Cells
Hamilton, A., Zhang, Q., Gao, R., Hill, T. G., Salehi, A., Knudsen, J. G., Draper, M., Johnson, P. R. V., Rorsman, P., & Tarasov, A. (2024) · Diabetes · doi:10.2337/db23-0809 · Cited by 5
Tobin, B. W., & Miller, G. D. (2001) · Journal of Nutrition · doi:10.1093/jn/131.2.333s · Cited by 6
Nicotinamide and insulin sensitivity
Paul, T. L. (1993) · Diabetologia · doi:10.1007/bf00400244 · Cited by 5
Kumakura, S., Iwamoto, Y., Kuzuya, T., Shiraishi, I., Matsuda, A., & Saito, T. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01127-7 · Cited by 4
Drug-Induced Diabetes Mellitus
Yi, D., & Kang, Y. H. (2017) · Journal of Korean Diabetes · doi:10.4093/jkd.2017.18.3.160 · Cited by 3
Ar'Rajab, A., & Åhrén, B. (1991) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(91)90095-u · Cited by 3
Gupta, N., Hoffman, R. P., & Veng‐Pedersen, P. (2006) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.499 · Cited by 3
Niacin: A therapeutic dilemma “one man's drink is another's poison”
Kreisberg, R. A. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90296-8 · Cited by 3
Consequences of human IAPP expression in transgenic mice
Verchere, C. B., D’Alessio, D. A., & Kahn, S. E. (1996) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4112-6_10 · Cited by 3
Self-citationD’Alessio, D. A., & Kahn, S. E. (2025) · Diabetes · doi:10.2337/dbi24-0049 · Cited by 2
Self-citationWahlberg, G., & Walldius, G. (1993) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02592289 · Cited by 2
Inoue, Y., Kaku, K., Okubo, M., Hatao, K., Hatao, M., Kaneko, T., Matsumura, S., Ando, S., & Fujii, S. (1994) · Current Medical Research and Opinion · doi:10.1185/03007999409110482 · Cited by 2
Impact of Drugs on Diabetes Risk and Glycemic Control
Frontoni, S., & Picconi, F. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_19-2 · Cited by 1
Impact of Drugs on Diabetes Risk and Glycemic Control
Frontoni, S., & Picconi, F. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_19 · Cited by 1
Normal Insulin Secretion in Humans
Utzschneider, K. M., Porte, D., & Kahn, S. E. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0205 · Cited by 1
Self-citationIs Chromium(III) Effective as a Therapeutic Agent?
(2012) · doi:10.1002/9781118458891.ch5 · Cited by 1
Role of Carbohydrates in the Prevention of Type 2 Diabetes
Wolever, T. M. S. (2013) · Wiley eBooks · doi:10.1002/9781118528723.ch10 · Cited by 1
Novel NAD+ metabolomic technologies and their applications to Nicotinamide Riboside interventions
Trammell, S. A. J., Wright, M. E., Piper, R. C., Brenner, C., Slusarski, D. C., & Wilson, M. E. (2016) · doi:10.17077/etd.mk206led · Cited by 1
Garg, A. (1990) · JAMA · doi:10.1001/jama.1990.03450230026020
Estudio del factor de transcripción SREBP1 en estados de resistencia a insulina.
Miralles, S. V. (2007) · DIGITAL.CSIC (Spanish National Research Council (CSIC))
The effects of hypoxis hemerocallidea on blood glucose levels in rats with Type 2 diabetes
Elshawesh, M. A. (2015) · University of the Western Cape Electronic Theses and Dissertations Repository (University of the Western Cape)
Karl, J. P., Meydani, S. N., & Roberts, S. B. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.160192
Impact of Drugs on Diabetes Risk and Glycemic Control
Frontoni, S., & Picconi, F. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_19-1
Impact of Drugs on Diabetes Risk and Glycemic Control
Frontoni, S., & Picconi, F. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_19
(2002) · Circulation · doi:10.1161/circ.106.25.3373
Daniel Porte Jr., 13 August 1931–13 May 2023
Kahn, S. E., Woods, S. C., Halter, J. B., Taborsky, G. J., & Schwartz, M. W. (2023) · Diabetes · doi:10.2337/db23-0787
Self-citationNiacin Therapy: Impact on Dyslipidemia and Cardiovascular Events in Diabetic Patients
Tran, H., Schwartzbard, A. Z., & Underberg, J. A. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_21
Nemukula, M., Malaisamy, A., Singh, S., Mkhwanazi, S., Mapheto, T. J., Mema, S., Lechaba, N. M. T., Bhavesh, N. S., Majane, O. H. I., & Gololo, S. S. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100538
Kannt, A., Pfenninger, A., Tönjes, A., & Blüher, M. (2015) · Diabetologia · doi:10.1007/s00125-015-3678-5
Menagerie of Chromium Supplements
Vincent, J. B. (2012) · Wiley eBooks · doi:10.1002/9781118458891.ch7
Metadata
- Authors
- Kahn, S. E., Beard, J. C., Schwartz, M. W., Ward, W. K., Ding, H. L., Bergman, R. N., Taborsky, G. J., & Porte, D.
- Affiliations
- University of Southern California (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1989-05-01
- Volume
- 38
- Issue
- 5
- Pages
- 562-568
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W1979102029
- Cited by
- 181
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 3 · 2016: 2 · 2015: 7 · 2014: 2 · 2013: 5 · 2012: 6
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 12829, DK-17047)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- nicotinic acid, insulin resistance, acute insulin response, arginine stimulation, proinsulin, insulin sensitivity, hyperinsulinemic-euglycemic clamp, Bergman minimal model, islet function
- MeSH terms
- Adult, Blood Glucose, Epinephrine, Glucagon, Humans, Hydrocortisone, Injections, Intravenous, Insulin Resistance, Islets of Langerhans, Male, Nicotinic Acids, Norepinephrine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
